DCLD with portal hypertension with grade I encephalopathy: A case report
DOI:
https://doi.org/10.64171/JAMS.2026.6.1.1-3Keywords:
Decompensated liver cirrhosis, Hepatic encephalopathy, Chronic liver failure, Portal hypertensionAbstract
Decompensated liver disease (DCLD) is a medical emergency that has a high mortality rate. DCLD is also associated with other complications such as visceral bleeding, ascites, hepatic encephalopathy, etc. In this case report, a 49-year-old male developed DCLD with portal hypertension and grade-I encephalopathy. Prognosis is generally poor in such conditions, but liver transplantation could be an option in end-stage liver failure.
References
Jagdish RK, Roy A, Kumar K, Premkumar M, Sharma M, Rao PN, et al. Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure. Frontiers in Medicine, 2023, 10.
Gülcicegi DE, Goeser T, Kasper P. Prognostic assessment of liver cirrhosis and its complications: current concepts and future perspectives. Frontiers in Medicine, 2023, 10.
Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. Journal of Hepatology. 2023;79(2):516-537.
Das M, Shil R. Awareness and influencing lifestyle modification factors regarding hepatitis B among non-medical students – efficacy of an educational package. International Journal of Advances in Nursing Management. 2022;10(4):285-291.
Mishra D, Dash KR, Khatua C, Panigrahi S, Parida PK, Behera SK, et al. Temporal trends in the etiology of cirrhosis of liver in coastal eastern Odisha. Euroasian Journal of Hepato-Gastroenterology. 2020;10(1):1–6.
Sinha S, Shil R. Knowledge and attitude towards liver cirrhosis due to alcoholism among commercial auto drivers in Bengaluru south region through VAT program: a pre-experimental study. International Journal of Advanced Research. 2023;11(2):118–128.
Cleveland Clinic. Hepatic encephalopathy, 2024. Available from: https://my.clevelandclinic.org/health/diseases/21220-hepatic-encephalopathy
Mandiga P, Kommu S, Bollu PC. Hepatic encephalopathy. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2025 Jan. Updated 2024 Mar 7. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430869/
Mansour D, McPherson S. Management of decompensated cirrhosis. Clinical Medicine (London). 2018;18(Suppl 2):s60-s65.
Trebicka J, Hernaez R, Shawcross DL, Gerbes AL. Advances in prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure and the role of biomarkers. Gut. 2024;73(6):1015-1024.
Ariza X, Graupera I, Coll M, Solà E, Barreto R, García E, et al. Neutrophil gelatinase-associated lipocalin as a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis. Journal of Hepatology. 2016;65(1):57-65.
GGC Medicines. Management of decompensated liver disease. Available from: https://handbook.ggcmedicines.org.uk/guidelines/gastrointestinal-system/management-of-decompensated-liver-disease/
Harrison PM. Management of patients with decompensated cirrhosis. Clinical Medicine. 2015;15(2):201-203.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Dr. Rahul Shil
This work is licensed under a Creative Commons Attribution 4.0 International License.
